nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—ABCB1—peripheral nervous system neoplasm	0.286	1	CbGaD
Nefazodone—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0566	0.132	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0566	0.132	CbGbCtD
Nefazodone—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0424	0.0987	CbGbCtD
Nefazodone—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0297	0.0691	CbGbCtD
Nefazodone—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0297	0.0691	CbGbCtD
Nefazodone—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.026	0.0604	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.026	0.0604	CbGbCtD
Nefazodone—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0206	0.0479	CbGbCtD
Nefazodone—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0195	0.0453	CbGbCtD
Nefazodone—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0179	0.0415	CbGbCtD
Nefazodone—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0178	0.0414	CbGbCtD
Nefazodone—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0165	0.0385	CbGbCtD
Nefazodone—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0127	0.0295	CbGbCtD
Nefazodone—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0118	0.0275	CbGbCtD
Nefazodone—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0116	0.027	CbGbCtD
Nefazodone—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00793	0.0184	CbGbCtD
Nefazodone—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0076	0.0177	CbGbCtD
Nefazodone—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00747	0.0174	CbGbCtD
Nefazodone—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00696	0.0162	CbGbCtD
Nefazodone—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.0053	0.188	CbGeAlD
Nefazodone—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00475	0.011	CbGbCtD
Nefazodone—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00194	0.0688	CbGeAlD
Nefazodone—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00181	0.0643	CbGeAlD
Nefazodone—SLC6A3—nerve—peripheral nervous system neoplasm	0.00146	0.0518	CbGeAlD
Nefazodone—SLC6A3—ganglion—peripheral nervous system neoplasm	0.00144	0.0511	CbGeAlD
Nefazodone—HTR2C—ganglion—peripheral nervous system neoplasm	0.00139	0.0494	CbGeAlD
Nefazodone—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00138	0.049	CbGeAlD
Nefazodone—HTR2A—pons—peripheral nervous system neoplasm	0.00136	0.0484	CbGeAlD
Nefazodone—SLC6A4—ganglion—peripheral nervous system neoplasm	0.00132	0.0469	CbGeAlD
Nefazodone—SLC6A2—nerve—peripheral nervous system neoplasm	0.00118	0.0418	CbGeAlD
Nefazodone—HTR1A—ganglion—peripheral nervous system neoplasm	0.00117	0.0416	CbGeAlD
Nefazodone—SLC6A2—ganglion—peripheral nervous system neoplasm	0.00116	0.0413	CbGeAlD
Nefazodone—HTR2A—nerve—peripheral nervous system neoplasm	0.000708	0.0251	CbGeAlD
Nefazodone—HTR2A—ganglion—peripheral nervous system neoplasm	0.000699	0.0248	CbGeAlD
Nefazodone—SLC6A3—brainstem—peripheral nervous system neoplasm	0.000627	0.0222	CbGeAlD
Nefazodone—HTR2C—brainstem—peripheral nervous system neoplasm	0.000606	0.0215	CbGeAlD
Nefazodone—SLC6A4—brainstem—peripheral nervous system neoplasm	0.000574	0.0204	CbGeAlD
Nefazodone—HTR1A—brainstem—peripheral nervous system neoplasm	0.00051	0.0181	CbGeAlD
Nefazodone—SLC6A2—brainstem—peripheral nervous system neoplasm	0.000506	0.0179	CbGeAlD
Nefazodone—ADRA1A—brainstem—peripheral nervous system neoplasm	0.00047	0.0167	CbGeAlD
Nefazodone—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.000404	0.0143	CbGeAlD
Nefazodone—SLC6A3—cerebellum—peripheral nervous system neoplasm	0.000309	0.011	CbGeAlD
Nefazodone—HTR2A—brainstem—peripheral nervous system neoplasm	0.000304	0.0108	CbGeAlD
Nefazodone—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000277	0.00982	CbGeAlD
Nefazodone—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000251	0.00892	CbGeAlD
Nefazodone—ADRA1A—cerebellum—peripheral nervous system neoplasm	0.000232	0.00822	CbGeAlD
Nefazodone—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000225	0.00798	CbGeAlD
Nefazodone—Domperidone—ABCB1—peripheral nervous system neoplasm	0.000217	0.241	CrCbGaD
Nefazodone—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.000176	0.00625	CbGeAlD
Nefazodone—Aripiprazole—ABCB1—peripheral nervous system neoplasm	0.000168	0.186	CrCbGaD
Nefazodone—Trazodone—ABCB1—peripheral nervous system neoplasm	0.000167	0.185	CrCbGaD
Nefazodone—HTR2A—cerebellum—peripheral nervous system neoplasm	0.00015	0.00531	CbGeAlD
Nefazodone—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000136	0.00484	CbGeAlD
Nefazodone—Fluphenazine—ABCB1—peripheral nervous system neoplasm	0.000135	0.15	CrCbGaD
Nefazodone—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000469	CcSEcCtD
Nefazodone—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000467	CcSEcCtD
Nefazodone—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000111	0.000466	CcSEcCtD
Nefazodone—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000111	0.000466	CcSEcCtD
Nefazodone—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000111	0.000464	CcSEcCtD
Nefazodone—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000111	0.000464	CcSEcCtD
Nefazodone—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000111	0.000464	CcSEcCtD
Nefazodone—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000463	CcSEcCtD
Nefazodone—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00011	0.000463	CcSEcCtD
Nefazodone—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.00046	CcSEcCtD
Nefazodone—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00011	0.00046	CcSEcCtD
Nefazodone—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000458	CcSEcCtD
Nefazodone—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000457	CcSEcCtD
Nefazodone—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000108	0.000453	CcSEcCtD
Nefazodone—Trifluoperazine—ABCB1—peripheral nervous system neoplasm	0.000108	0.12	CrCbGaD
Nefazodone—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000452	CcSEcCtD
Nefazodone—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000108	0.000451	CcSEcCtD
Nefazodone—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000451	CcSEcCtD
Nefazodone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000107	0.000449	CcSEcCtD
Nefazodone—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000107	0.000449	CcSEcCtD
Nefazodone—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000106	0.000444	CcSEcCtD
Nefazodone—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000444	CcSEcCtD
Nefazodone—Pain—Cisplatin—peripheral nervous system neoplasm	0.000106	0.000444	CcSEcCtD
Nefazodone—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000443	CcSEcCtD
Nefazodone—Quetiapine—ABCB1—peripheral nervous system neoplasm	0.000105	0.116	CrCbGaD
Nefazodone—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000438	CcSEcCtD
Nefazodone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000104	0.000437	CcSEcCtD
Nefazodone—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000437	CcSEcCtD
Nefazodone—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000434	CcSEcCtD
Nefazodone—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000434	CcSEcCtD
Nefazodone—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000434	CcSEcCtD
Nefazodone—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000433	CcSEcCtD
Nefazodone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000103	0.000432	CcSEcCtD
Nefazodone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000103	0.000431	CcSEcCtD
Nefazodone—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000428	CcSEcCtD
Nefazodone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000102	0.000428	CcSEcCtD
Nefazodone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000102	0.000427	CcSEcCtD
Nefazodone—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000427	CcSEcCtD
Nefazodone—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000424	CcSEcCtD
Nefazodone—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000101	0.000424	CcSEcCtD
Nefazodone—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000101	0.000423	CcSEcCtD
Nefazodone—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000422	CcSEcCtD
Nefazodone—Asthenia—Vincristine—peripheral nervous system neoplasm	0.0001	0.000421	CcSEcCtD
Nefazodone—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.0001	0.00042	CcSEcCtD
Nefazodone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	9.96e-05	0.000418	CcSEcCtD
Nefazodone—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	9.95e-05	0.000417	CcSEcCtD
Nefazodone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	9.94e-05	0.000417	CcSEcCtD
Nefazodone—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	9.88e-05	0.000414	CcSEcCtD
Nefazodone—Rash—Dactinomycin—peripheral nervous system neoplasm	9.88e-05	0.000414	CcSEcCtD
Nefazodone—Decreased appetite—Etoposide—peripheral nervous system neoplasm	9.86e-05	0.000413	CcSEcCtD
Nefazodone—ABCB1—cerebellum—peripheral nervous system neoplasm	9.82e-05	0.00348	CbGeAlD
Nefazodone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	9.79e-05	0.00041	CcSEcCtD
Nefazodone—Stomatitis—Epirubicin—peripheral nervous system neoplasm	9.72e-05	0.000407	CcSEcCtD
Nefazodone—Pain—Etoposide—peripheral nervous system neoplasm	9.7e-05	0.000407	CcSEcCtD
Nefazodone—Constipation—Etoposide—peripheral nervous system neoplasm	9.7e-05	0.000407	CcSEcCtD
Nefazodone—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	9.69e-05	0.000406	CcSEcCtD
Nefazodone—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	9.69e-05	0.000406	CcSEcCtD
Nefazodone—Dysuria—Doxorubicin—peripheral nervous system neoplasm	9.67e-05	0.000406	CcSEcCtD
Nefazodone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	9.61e-05	0.000403	CcSEcCtD
Nefazodone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	9.58e-05	0.000402	CcSEcCtD
Nefazodone—Sweating—Epirubicin—peripheral nervous system neoplasm	9.56e-05	0.000401	CcSEcCtD
Nefazodone—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	9.56e-05	0.000401	CcSEcCtD
Nefazodone—Haematuria—Epirubicin—peripheral nervous system neoplasm	9.51e-05	0.000398	CcSEcCtD
Nefazodone—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	9.44e-05	0.000396	CcSEcCtD
Nefazodone—Weight increased—Doxorubicin—peripheral nervous system neoplasm	9.41e-05	0.000395	CcSEcCtD
Nefazodone—Epistaxis—Epirubicin—peripheral nervous system neoplasm	9.4e-05	0.000394	CcSEcCtD
Nefazodone—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	9.36e-05	0.000392	CcSEcCtD
Nefazodone—Sinusitis—Epirubicin—peripheral nervous system neoplasm	9.35e-05	0.000392	CcSEcCtD
Nefazodone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	9.35e-05	0.000392	CcSEcCtD
Nefazodone—Nausea—Dactinomycin—peripheral nervous system neoplasm	9.31e-05	0.00039	CcSEcCtD
Nefazodone—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	9.28e-05	0.000389	CcSEcCtD
Nefazodone—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	9.28e-05	0.000389	CcSEcCtD
Nefazodone—Dizziness—Vincristine—peripheral nervous system neoplasm	9.26e-05	0.000388	CcSEcCtD
Nefazodone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	9.24e-05	0.000387	CcSEcCtD
Nefazodone—Rash—Alitretinoin—peripheral nervous system neoplasm	9.16e-05	0.000384	CcSEcCtD
Nefazodone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	9.15e-05	0.000384	CcSEcCtD
Nefazodone—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	9.14e-05	0.000383	CcSEcCtD
Nefazodone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	9.12e-05	0.000382	CcSEcCtD
Nefazodone—Bradycardia—Epirubicin—peripheral nervous system neoplasm	9.11e-05	0.000382	CcSEcCtD
Nefazodone—Headache—Alitretinoin—peripheral nervous system neoplasm	9.1e-05	0.000382	CcSEcCtD
Nefazodone—Urticaria—Etoposide—peripheral nervous system neoplasm	9.01e-05	0.000378	CcSEcCtD
Nefazodone—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	8.99e-05	0.000377	CcSEcCtD
Nefazodone—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	8.99e-05	0.000377	CcSEcCtD
Nefazodone—Rhinitis—Epirubicin—peripheral nervous system neoplasm	8.97e-05	0.000376	CcSEcCtD
Nefazodone—Abdominal pain—Etoposide—peripheral nervous system neoplasm	8.97e-05	0.000376	CcSEcCtD
Nefazodone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	8.97e-05	0.000376	CcSEcCtD
Nefazodone—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	8.97e-05	0.000376	CcSEcCtD
Nefazodone—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	8.97e-05	0.000376	CcSEcCtD
Nefazodone—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	8.95e-05	0.000375	CcSEcCtD
Nefazodone—Hepatitis—Epirubicin—peripheral nervous system neoplasm	8.95e-05	0.000375	CcSEcCtD
Nefazodone—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	8.9e-05	0.000373	CcSEcCtD
Nefazodone—Vomiting—Vincristine—peripheral nervous system neoplasm	8.9e-05	0.000373	CcSEcCtD
Nefazodone—Asthenia—Cisplatin—peripheral nervous system neoplasm	8.88e-05	0.000372	CcSEcCtD
Nefazodone—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	8.88e-05	0.000372	CcSEcCtD
Nefazodone—Sweating—Doxorubicin—peripheral nervous system neoplasm	8.84e-05	0.000371	CcSEcCtD
Nefazodone—Rash—Vincristine—peripheral nervous system neoplasm	8.83e-05	0.00037	CcSEcCtD
Nefazodone—Dermatitis—Vincristine—peripheral nervous system neoplasm	8.82e-05	0.00037	CcSEcCtD
Nefazodone—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	8.82e-05	0.00037	CcSEcCtD
Nefazodone—Haematuria—Doxorubicin—peripheral nervous system neoplasm	8.79e-05	0.000369	CcSEcCtD
Nefazodone—Headache—Vincristine—peripheral nervous system neoplasm	8.77e-05	0.000368	CcSEcCtD
Nefazodone—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	8.7e-05	0.000365	CcSEcCtD
Nefazodone—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	8.65e-05	0.000363	CcSEcCtD
Nefazodone—Nausea—Alitretinoin—peripheral nervous system neoplasm	8.63e-05	0.000362	CcSEcCtD
Nefazodone—Visual impairment—Epirubicin—peripheral nervous system neoplasm	8.62e-05	0.000362	CcSEcCtD
Nefazodone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	8.47e-05	0.000355	CcSEcCtD
Nefazodone—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	8.46e-05	0.000355	CcSEcCtD
Nefazodone—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	8.43e-05	0.000353	CcSEcCtD
Nefazodone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	8.36e-05	0.00035	CcSEcCtD
Nefazodone—Tinnitus—Epirubicin—peripheral nervous system neoplasm	8.34e-05	0.00035	CcSEcCtD
Nefazodone—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	8.32e-05	0.000349	CcSEcCtD
Nefazodone—Nausea—Vincristine—peripheral nervous system neoplasm	8.32e-05	0.000349	CcSEcCtD
Nefazodone—Flushing—Epirubicin—peripheral nervous system neoplasm	8.31e-05	0.000348	CcSEcCtD
Nefazodone—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	8.3e-05	0.000348	CcSEcCtD
Nefazodone—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	8.28e-05	0.000347	CcSEcCtD
Nefazodone—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	8.28e-05	0.000347	CcSEcCtD
Nefazodone—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	8.24e-05	0.000345	CcSEcCtD
Nefazodone—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	8.22e-05	0.000345	CcSEcCtD
Nefazodone—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	8.16e-05	0.000342	CcSEcCtD
Nefazodone—Asthenia—Etoposide—peripheral nervous system neoplasm	8.14e-05	0.000341	CcSEcCtD
Nefazodone—Chills—Epirubicin—peripheral nervous system neoplasm	8.03e-05	0.000337	CcSEcCtD
Nefazodone—Pruritus—Etoposide—peripheral nervous system neoplasm	8.02e-05	0.000336	CcSEcCtD
Nefazodone—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	7.98e-05	0.000335	CcSEcCtD
Nefazodone—Alopecia—Epirubicin—peripheral nervous system neoplasm	7.91e-05	0.000331	CcSEcCtD
Nefazodone—Vomiting—Cisplatin—peripheral nervous system neoplasm	7.87e-05	0.00033	CcSEcCtD
Nefazodone—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	7.83e-05	0.000328	CcSEcCtD
Nefazodone—Rash—Cisplatin—peripheral nervous system neoplasm	7.81e-05	0.000327	CcSEcCtD
Nefazodone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	7.8e-05	0.000327	CcSEcCtD
Nefazodone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	7.76e-05	0.000325	CcSEcCtD
Nefazodone—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	7.72e-05	0.000324	CcSEcCtD
Nefazodone—Flushing—Doxorubicin—peripheral nervous system neoplasm	7.69e-05	0.000322	CcSEcCtD
Nefazodone—Flatulence—Epirubicin—peripheral nervous system neoplasm	7.68e-05	0.000322	CcSEcCtD
Nefazodone—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	7.63e-05	0.00032	CcSEcCtD
Nefazodone—Back pain—Epirubicin—peripheral nervous system neoplasm	7.54e-05	0.000316	CcSEcCtD
Nefazodone—Dizziness—Etoposide—peripheral nervous system neoplasm	7.5e-05	0.000314	CcSEcCtD
Nefazodone—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	7.49e-05	0.000314	CcSEcCtD
Nefazodone—Chills—Doxorubicin—peripheral nervous system neoplasm	7.43e-05	0.000311	CcSEcCtD
Nefazodone—Nausea—Cisplatin—peripheral nervous system neoplasm	7.35e-05	0.000308	CcSEcCtD
Nefazodone—Vision blurred—Epirubicin—peripheral nervous system neoplasm	7.34e-05	0.000308	CcSEcCtD
Nefazodone—Alopecia—Doxorubicin—peripheral nervous system neoplasm	7.32e-05	0.000307	CcSEcCtD
Nefazodone—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	7.23e-05	0.000303	CcSEcCtD
Nefazodone—Vomiting—Etoposide—peripheral nervous system neoplasm	7.21e-05	0.000302	CcSEcCtD
Nefazodone—Anaemia—Epirubicin—peripheral nervous system neoplasm	7.2e-05	0.000302	CcSEcCtD
Nefazodone—Agitation—Epirubicin—peripheral nervous system neoplasm	7.16e-05	0.0003	CcSEcCtD
Nefazodone—Rash—Etoposide—peripheral nervous system neoplasm	7.15e-05	0.0003	CcSEcCtD
Nefazodone—Dermatitis—Etoposide—peripheral nervous system neoplasm	7.15e-05	0.0003	CcSEcCtD
Nefazodone—Headache—Etoposide—peripheral nervous system neoplasm	7.11e-05	0.000298	CcSEcCtD
Nefazodone—Flatulence—Doxorubicin—peripheral nervous system neoplasm	7.1e-05	0.000298	CcSEcCtD
Nefazodone—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	7.06e-05	0.000296	CcSEcCtD
Nefazodone—Malaise—Epirubicin—peripheral nervous system neoplasm	7.03e-05	0.000294	CcSEcCtD
Nefazodone—Vertigo—Epirubicin—peripheral nervous system neoplasm	7e-05	0.000293	CcSEcCtD
Nefazodone—Syncope—Epirubicin—peripheral nervous system neoplasm	6.99e-05	0.000293	CcSEcCtD
Nefazodone—Leukopenia—Epirubicin—peripheral nervous system neoplasm	6.97e-05	0.000292	CcSEcCtD
Nefazodone—Back pain—Doxorubicin—peripheral nervous system neoplasm	6.97e-05	0.000292	CcSEcCtD
Nefazodone—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	6.93e-05	0.000291	CcSEcCtD
Nefazodone—Palpitations—Epirubicin—peripheral nervous system neoplasm	6.88e-05	0.000289	CcSEcCtD
Nefazodone—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	6.85e-05	0.000287	CcSEcCtD
Nefazodone—Cough—Epirubicin—peripheral nervous system neoplasm	6.8e-05	0.000285	CcSEcCtD
Nefazodone—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	6.79e-05	0.000285	CcSEcCtD
Nefazodone—Convulsion—Epirubicin—peripheral nervous system neoplasm	6.75e-05	0.000283	CcSEcCtD
Nefazodone—Nausea—Etoposide—peripheral nervous system neoplasm	6.74e-05	0.000282	CcSEcCtD
Nefazodone—Hypertension—Epirubicin—peripheral nervous system neoplasm	6.73e-05	0.000282	CcSEcCtD
Nefazodone—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	6.69e-05	0.00028	CcSEcCtD
Nefazodone—Anaemia—Doxorubicin—peripheral nervous system neoplasm	6.66e-05	0.000279	CcSEcCtD
Nefazodone—Myalgia—Epirubicin—peripheral nervous system neoplasm	6.63e-05	0.000278	CcSEcCtD
Nefazodone—Arthralgia—Epirubicin—peripheral nervous system neoplasm	6.63e-05	0.000278	CcSEcCtD
Nefazodone—Chest pain—Epirubicin—peripheral nervous system neoplasm	6.63e-05	0.000278	CcSEcCtD
Nefazodone—Agitation—Doxorubicin—peripheral nervous system neoplasm	6.62e-05	0.000278	CcSEcCtD
Nefazodone—Anxiety—Epirubicin—peripheral nervous system neoplasm	6.61e-05	0.000277	CcSEcCtD
Nefazodone—Discomfort—Epirubicin—peripheral nervous system neoplasm	6.55e-05	0.000275	CcSEcCtD
Nefazodone—Malaise—Doxorubicin—peripheral nervous system neoplasm	6.5e-05	0.000272	CcSEcCtD
Nefazodone—Dry mouth—Epirubicin—peripheral nervous system neoplasm	6.49e-05	0.000272	CcSEcCtD
Nefazodone—Vertigo—Doxorubicin—peripheral nervous system neoplasm	6.48e-05	0.000271	CcSEcCtD
Nefazodone—Syncope—Doxorubicin—peripheral nervous system neoplasm	6.46e-05	0.000271	CcSEcCtD
Nefazodone—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	6.45e-05	0.00027	CcSEcCtD
Nefazodone—Confusional state—Epirubicin—peripheral nervous system neoplasm	6.41e-05	0.000269	CcSEcCtD
Nefazodone—Palpitations—Doxorubicin—peripheral nervous system neoplasm	6.37e-05	0.000267	CcSEcCtD
Nefazodone—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	6.36e-05	0.000267	CcSEcCtD
Nefazodone—Oedema—Epirubicin—peripheral nervous system neoplasm	6.36e-05	0.000267	CcSEcCtD
Nefazodone—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	6.34e-05	0.000266	CcSEcCtD
Nefazodone—Infection—Epirubicin—peripheral nervous system neoplasm	6.32e-05	0.000265	CcSEcCtD
Nefazodone—Cough—Doxorubicin—peripheral nervous system neoplasm	6.29e-05	0.000264	CcSEcCtD
Nefazodone—Shock—Epirubicin—peripheral nervous system neoplasm	6.26e-05	0.000262	CcSEcCtD
Nefazodone—Convulsion—Doxorubicin—peripheral nervous system neoplasm	6.25e-05	0.000262	CcSEcCtD
Nefazodone—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	6.23e-05	0.000261	CcSEcCtD
Nefazodone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	6.22e-05	0.000261	CcSEcCtD
Nefazodone—Tachycardia—Epirubicin—peripheral nervous system neoplasm	6.21e-05	0.00026	CcSEcCtD
Nefazodone—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	6.15e-05	0.000258	CcSEcCtD
Nefazodone—Chest pain—Doxorubicin—peripheral nervous system neoplasm	6.14e-05	0.000257	CcSEcCtD
Nefazodone—Myalgia—Doxorubicin—peripheral nervous system neoplasm	6.14e-05	0.000257	CcSEcCtD
Nefazodone—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	6.14e-05	0.000257	CcSEcCtD
Nefazodone—Anxiety—Doxorubicin—peripheral nervous system neoplasm	6.12e-05	0.000256	CcSEcCtD
Nefazodone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	6.06e-05	0.000254	CcSEcCtD
Nefazodone—Anorexia—Epirubicin—peripheral nervous system neoplasm	6.06e-05	0.000254	CcSEcCtD
Nefazodone—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	6e-05	0.000252	CcSEcCtD
Nefazodone—Hypotension—Epirubicin—peripheral nervous system neoplasm	5.94e-05	0.000249	CcSEcCtD
Nefazodone—Confusional state—Doxorubicin—peripheral nervous system neoplasm	5.93e-05	0.000249	CcSEcCtD
Nefazodone—Oedema—Doxorubicin—peripheral nervous system neoplasm	5.88e-05	0.000247	CcSEcCtD
Nefazodone—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	5.88e-05	0.000247	CcSEcCtD
Nefazodone—Infection—Doxorubicin—peripheral nervous system neoplasm	5.84e-05	0.000245	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	5.79e-05	0.000243	CcSEcCtD
Nefazodone—Shock—Doxorubicin—peripheral nervous system neoplasm	5.79e-05	0.000243	CcSEcCtD
Nefazodone—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	5.76e-05	0.000241	CcSEcCtD
Nefazodone—Insomnia—Epirubicin—peripheral nervous system neoplasm	5.75e-05	0.000241	CcSEcCtD
Nefazodone—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	5.74e-05	0.000241	CcSEcCtD
Nefazodone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	5.71e-05	0.000239	CcSEcCtD
Nefazodone—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	5.69e-05	0.000238	CcSEcCtD
Nefazodone—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	5.67e-05	0.000238	CcSEcCtD
Nefazodone—Somnolence—Epirubicin—peripheral nervous system neoplasm	5.65e-05	0.000237	CcSEcCtD
Nefazodone—Anorexia—Doxorubicin—peripheral nervous system neoplasm	5.61e-05	0.000235	CcSEcCtD
Nefazodone—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	5.6e-05	0.000235	CcSEcCtD
Nefazodone—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	5.53e-05	0.000232	CcSEcCtD
Nefazodone—Hypotension—Doxorubicin—peripheral nervous system neoplasm	5.5e-05	0.00023	CcSEcCtD
Nefazodone—Constipation—Epirubicin—peripheral nervous system neoplasm	5.44e-05	0.000228	CcSEcCtD
Nefazodone—Pain—Epirubicin—peripheral nervous system neoplasm	5.44e-05	0.000228	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	5.36e-05	0.000225	CcSEcCtD
Nefazodone—Insomnia—Doxorubicin—peripheral nervous system neoplasm	5.32e-05	0.000223	CcSEcCtD
Nefazodone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	5.28e-05	0.000221	CcSEcCtD
Nefazodone—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	5.24e-05	0.00022	CcSEcCtD
Nefazodone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	5.24e-05	0.00022	CcSEcCtD
Nefazodone—Somnolence—Doxorubicin—peripheral nervous system neoplasm	5.23e-05	0.000219	CcSEcCtD
Nefazodone—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	5.2e-05	0.000218	CcSEcCtD
Nefazodone—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	5.18e-05	0.000217	CcSEcCtD
Nefazodone—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	5.11e-05	0.000214	CcSEcCtD
Nefazodone—Urticaria—Epirubicin—peripheral nervous system neoplasm	5.05e-05	0.000212	CcSEcCtD
Nefazodone—Pain—Doxorubicin—peripheral nervous system neoplasm	5.03e-05	0.000211	CcSEcCtD
Nefazodone—Constipation—Doxorubicin—peripheral nervous system neoplasm	5.03e-05	0.000211	CcSEcCtD
Nefazodone—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	5.03e-05	0.000211	CcSEcCtD
Nefazodone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	5.03e-05	0.000211	CcSEcCtD
Nefazodone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	4.85e-05	0.000203	CcSEcCtD
Nefazodone—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	4.81e-05	0.000202	CcSEcCtD
Nefazodone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4.68e-05	0.000196	CcSEcCtD
Nefazodone—Urticaria—Doxorubicin—peripheral nervous system neoplasm	4.67e-05	0.000196	CcSEcCtD
Nefazodone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	4.65e-05	0.000195	CcSEcCtD
Nefazodone—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	4.65e-05	0.000195	CcSEcCtD
Nefazodone—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.56e-05	0.000191	CcSEcCtD
Nefazodone—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.5e-05	0.000189	CcSEcCtD
Nefazodone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.35e-05	0.000182	CcSEcCtD
Nefazodone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	4.33e-05	0.000182	CcSEcCtD
Nefazodone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.000177	CcSEcCtD
Nefazodone—Dizziness—Epirubicin—peripheral nervous system neoplasm	4.2e-05	0.000176	CcSEcCtD
Nefazodone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	4.16e-05	0.000174	CcSEcCtD
Nefazodone—Vomiting—Epirubicin—peripheral nervous system neoplasm	4.04e-05	0.000169	CcSEcCtD
Nefazodone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.03e-05	0.000169	CcSEcCtD
Nefazodone—Rash—Epirubicin—peripheral nervous system neoplasm	4.01e-05	0.000168	CcSEcCtD
Nefazodone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	4.01e-05	0.000168	CcSEcCtD
Nefazodone—Headache—Epirubicin—peripheral nervous system neoplasm	3.98e-05	0.000167	CcSEcCtD
Nefazodone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.89e-05	0.000163	CcSEcCtD
Nefazodone—Nausea—Epirubicin—peripheral nervous system neoplasm	3.78e-05	0.000158	CcSEcCtD
Nefazodone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.74e-05	0.000157	CcSEcCtD
Nefazodone—Rash—Doxorubicin—peripheral nervous system neoplasm	3.71e-05	0.000155	CcSEcCtD
Nefazodone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.71e-05	0.000155	CcSEcCtD
Nefazodone—Headache—Doxorubicin—peripheral nervous system neoplasm	3.69e-05	0.000154	CcSEcCtD
Nefazodone—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.49e-05	0.000146	CcSEcCtD
Nefazodone—SLC6A4—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	1.94e-05	0.00118	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	1.93e-05	0.00118	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	1.93e-05	0.00118	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—COX2—peripheral nervous system neoplasm	1.91e-05	0.00117	CbGpPWpGaD
Nefazodone—SLC6A3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.91e-05	0.00116	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	1.91e-05	0.00116	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	1.89e-05	0.00115	CbGpPWpGaD
Nefazodone—SLC6A3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.87e-05	0.00114	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—KNG1—peripheral nervous system neoplasm	1.81e-05	0.00111	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	1.78e-05	0.00109	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	1.77e-05	0.00108	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	1.75e-05	0.00107	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	1.74e-05	0.00106	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.74e-05	0.00106	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.73e-05	0.00106	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.67e-05	0.00102	CbGpPWpGaD
Nefazodone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	1.66e-05	0.00101	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.66e-05	0.00101	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.66e-05	0.00101	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—GNS—peripheral nervous system neoplasm	1.63e-05	0.000998	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	1.62e-05	0.000988	CbGpPWpGaD
Nefazodone—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	1.59e-05	0.000971	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.59e-05	0.000969	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—GNAS—peripheral nervous system neoplasm	1.58e-05	0.000967	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—NME1—peripheral nervous system neoplasm	1.57e-05	0.000957	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.56e-05	0.000954	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—HGF—peripheral nervous system neoplasm	1.51e-05	0.000921	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—COX2—peripheral nervous system neoplasm	1.51e-05	0.000921	CbGpPWpGaD
Nefazodone—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.51e-05	0.000921	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.5e-05	0.000917	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	1.5e-05	0.000914	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.47e-05	0.000899	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.47e-05	0.000898	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.46e-05	0.000889	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.45e-05	0.000885	CbGpPWpGaD
Nefazodone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	1.44e-05	0.000881	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.44e-05	0.000879	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	1.44e-05	0.000877	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.43e-05	0.00087	CbGpPWpGaD
Nefazodone—SLC6A3—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.42e-05	0.000864	CbGpPWpGaD
Nefazodone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	1.41e-05	0.000862	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.41e-05	0.000861	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.39e-05	0.000847	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	1.38e-05	0.000844	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.37e-05	0.000834	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.32e-05	0.000807	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.32e-05	0.000804	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.32e-05	0.000803	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.31e-05	0.000801	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.31e-05	0.0008	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.31e-05	0.0008	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.27e-05	0.000777	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.27e-05	0.000773	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.26e-05	0.000769	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.26e-05	0.000768	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—ENO2—peripheral nervous system neoplasm	1.26e-05	0.000766	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.26e-05	0.000766	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.23e-05	0.000752	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.22e-05	0.000742	CbGpPWpGaD
Nefazodone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.22e-05	0.000742	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.21e-05	0.00074	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.21e-05	0.000739	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.19e-05	0.000727	CbGpPWpGaD
Nefazodone—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.18e-05	0.000719	CbGpPWpGaD
Nefazodone—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.16e-05	0.00071	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.16e-05	0.000707	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.16e-05	0.000706	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.15e-05	0.000702	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.14e-05	0.000699	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.14e-05	0.000698	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.14e-05	0.000695	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.13e-05	0.00069	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.12e-05	0.000683	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.11e-05	0.00068	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.1e-05	0.000672	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—PTPN11—peripheral nervous system neoplasm	1.1e-05	0.000672	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.1e-05	0.000672	CbGpPWpGaD
Nefazodone—SLC6A3—Neuronal System—HRAS—peripheral nervous system neoplasm	1.08e-05	0.000662	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.08e-05	0.000661	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.08e-05	0.000658	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	1.07e-05	0.00065	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	1.06e-05	0.000648	CbGpPWpGaD
Nefazodone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.06e-05	0.000644	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.05e-05	0.000641	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.04e-05	0.000637	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.04e-05	0.000635	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.04e-05	0.000632	CbGpPWpGaD
Nefazodone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.03e-05	0.000631	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.03e-05	0.000628	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	1.02e-05	0.000623	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.01e-05	0.000618	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1e-05	0.000611	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	9.99e-06	0.00061	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	9.97e-06	0.000609	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—ENO2—peripheral nervous system neoplasm	9.9e-06	0.000604	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	9.83e-06	0.0006	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	9.79e-06	0.000597	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.63e-06	0.000588	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	9.56e-06	0.000583	CbGpPWpGaD
Nefazodone—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.48e-06	0.000579	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	9.3e-06	0.000567	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	9.14e-06	0.000558	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	9.09e-06	0.000555	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	9.09e-06	0.000555	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	9.08e-06	0.000554	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	8.7e-06	0.000531	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—BCHE—peripheral nervous system neoplasm	8.37e-06	0.000511	CbGpPWpGaD
Nefazodone—ADRA2A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	8.3e-06	0.000506	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	8.14e-06	0.000497	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	8.04e-06	0.000491	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	8e-06	0.000488	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	7.99e-06	0.000488	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.98e-06	0.000487	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	7.89e-06	0.000482	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—TH—peripheral nervous system neoplasm	7.87e-06	0.00048	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.81e-06	0.000477	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.77e-06	0.000474	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	7.73e-06	0.000472	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	7.67e-06	0.000468	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	7.66e-06	0.000467	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	7.63e-06	0.000466	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	7.45e-06	0.000455	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.44e-06	0.000454	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	7.41e-06	0.000452	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.32e-06	0.000447	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	7.21e-06	0.00044	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	7.18e-06	0.000438	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	7.09e-06	0.000433	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	6.96e-06	0.000425	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	6.95e-06	0.000424	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	6.85e-06	0.000418	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.83e-06	0.000417	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	6.8e-06	0.000415	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.8e-06	0.000415	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	6.75e-06	0.000412	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	6.68e-06	0.000408	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—NRAS—peripheral nervous system neoplasm	6.62e-06	0.000404	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	6.61e-06	0.000403	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.51e-06	0.000397	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	6.45e-06	0.000394	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	6.45e-06	0.000393	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	6.43e-06	0.000393	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	6.43e-06	0.000392	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—GNAS—peripheral nervous system neoplasm	6.42e-06	0.000392	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	6.32e-06	0.000386	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—ABCB1—peripheral nervous system neoplasm	6.3e-06	0.000385	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	6.3e-06	0.000385	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	6.14e-06	0.000375	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.9e-06	0.00036	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	5.89e-06	0.000359	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.85e-06	0.000357	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	5.79e-06	0.000353	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.78e-06	0.000353	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	5.78e-06	0.000353	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.52e-06	0.000337	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	5.45e-06	0.000333	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	5.44e-06	0.000332	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.37e-06	0.000328	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.2e-06	0.000318	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	5.13e-06	0.000313	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	5.06e-06	0.000309	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	4.84e-06	0.000296	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.83e-06	0.000295	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.81e-06	0.000293	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.75e-06	0.00029	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.72e-06	0.000288	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.6e-06	0.000281	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.52e-06	0.000276	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	4.44e-06	0.000271	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	4.28e-06	0.000261	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	4.22e-06	0.000258	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	4.19e-06	0.000255	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.18e-06	0.000255	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	4.11e-06	0.000251	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.1e-06	0.00025	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.09e-06	0.00025	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.02e-06	0.000245	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.8e-06	0.000232	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.75e-06	0.000229	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.73e-06	0.000228	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.73e-06	0.000228	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.57e-06	0.000218	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	3.57e-06	0.000218	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.54e-06	0.000216	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.52e-06	0.000215	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.44e-06	0.00021	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.42e-06	0.000209	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.41e-06	0.000208	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.4e-06	0.000208	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.39e-06	0.000207	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.37e-06	0.000206	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	3.35e-06	0.000205	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.27e-06	0.0002	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.24e-06	0.000198	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.24e-06	0.000198	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.17e-06	0.000194	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.12e-06	0.000191	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.11e-06	0.00019	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.05e-06	0.000186	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.99e-06	0.000183	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.97e-06	0.000181	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.97e-06	0.000181	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.95e-06	0.00018	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.94e-06	0.00018	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.91e-06	0.000178	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.88e-06	0.000176	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.86e-06	0.000174	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.84e-06	0.000173	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.78e-06	0.00017	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	2.74e-06	0.000167	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.72e-06	0.000166	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.7e-06	0.000165	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.7e-06	0.000165	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.69e-06	0.000164	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.68e-06	0.000163	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.66e-06	0.000162	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.65e-06	0.000161	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.64e-06	0.000161	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.53e-06	0.000155	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.47e-06	0.000151	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.45e-06	0.00015	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.42e-06	0.000147	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.3e-06	0.00014	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.25e-06	0.000137	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.24e-06	0.000137	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	2.2e-06	0.000134	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.18e-06	0.000133	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.17e-06	0.000133	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.09e-06	0.000128	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.09e-06	0.000127	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.08e-06	0.000127	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.08e-06	0.000127	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.99e-06	0.000121	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.89e-06	0.000115	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.85e-06	0.000113	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.84e-06	0.000113	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.84e-06	0.000112	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.8e-06	0.00011	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.77e-06	0.000108	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.76e-06	0.000107	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	1.73e-06	0.000106	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.72e-06	0.000105	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.64e-06	0.0001	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.59e-06	9.73e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	1.59e-06	9.7e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.56e-06	9.52e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.45e-06	8.85e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.2e-06	7.32e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	1.13e-06	6.9e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	7.39e-07	4.51e-05	CbGpPWpGaD
